Glutathione S-transferase-μ1 regulates vascular smooth muscle cell proliferation, migration, and oxidative stress

Hypertension

Volumn 54, Issue 6, 2009, Pages 1360-1368

  Yang, Yanqiang ^a   Parsons, Kelly K ^a   Chi, Liqun ^a   Malakauskas, Sandra M ^b   Le, Thu H ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Glutathione S transferase 1; Migration; Proliferation; Reactive oxygen species; Vascular smooth muscle cells

Indexed keywords

GLUTATHIONE TRANSFERASE M1; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE; TEMPOL; AMINE OXIDE; ANTIOXIDANT; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; OXIDIZING AGENT;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; C57BL 6 MOUSE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CELL CULTURE; CELL DIVISION; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SPECIES DIFFERENCE; SPIN LABELING;

ANIMALS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CYCLIC N-OXIDES; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; OXIDANTS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SPECIES SPECIFICITY; SPIN LABELS;

EID: 73349118815     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.139428     Document Type: Article

References (38)

1. Landi S, Norppa H, Frenzilli G, Cipollini G, Ponzanelli I, Barale R, Hirvonen A. Individual sensitivity to cytogenetic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics. 1998;8: 461-471
2. Strange RC, Faulder CG, Davis BA, Hume R, Brown JA, Cotton W, Hopkinson DA. The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet. 1984;48:11-20
3. Takahashi Y, Campbell EA, Hirata Y, Takayama T, Listowsky I. A basis for differentiating among the multiple human Mu-glutathione S-transferases and molecular cloning of brain GSTM5. J Biol Chem. 1993;268:8893-8898
4. Guo J, Zimniak L, Zimniak P, Orchard JL, Singh SV. Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. Biochem J. 2002;366:817-824
5. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88
6. Mitchell AE, Morin D, Lakritz J, Jones AD. Quantitative profiling of tissue-and gender-related expression of glutathione S-transferase isoenzymes in the mouse. Biochem J. 1997;325:207-216
7. Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I, Brinkman U. Characterization of the glutathione S-transferase GSTT1 deletion: Discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics. 2000;10:557-565
8. Xu SJ, Wang Y, Roe B, Pearson WR. Characterization of the human class mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem. 1998;273:3517-3527
9. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh L, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239-1248
10. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000;151:7-32 (Pubitemid 30470391)
11. Hou SM, Ryberg D, Falt S, Deverill A, Tefre T, Borresen AL, Haugen A, Lambert B. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients. Carcinogenesis. 2000;21:49-54
12. Delles C, Braga-Marcano AC, Munroe PB, Padmanabhan S, McClure JD, Brain NJ, Brown MJ, Samani NJ, Clayton D, Farrall M, Webster J, Connell JM, Caulfield MJ, Dominiczak AF. Association between variants of the human GSTM gene family and hypertension [abstract]. Hypertension. 2006;48:A
13. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. J Cardiovasc Risk. 2002;9:25-31 (Pubitemid 34311430)
14. Izzotti A, Cartiglia C, Lewtas J, De Flora S. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 2001;15:752-757
15. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev. 2000;80:135-172
16. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ, Dominiczak AF. Microarray analysis of rat chromosome 2 congenic strains. Hypertension. 2003;41:847-853
17. McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, Hanlon N, Hamilton CA, Polke JM, Lee WK, Dominiczak AF. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension. 2005; 45:786-792
18. Le TH, Fogo AB, Salzler HR, Vinogradova T, Oliverio MI, Marchuk DA, Coffman TM. Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptor-deficiency. Hypertension. 2004;43: 445-451
19. Malakauskas SM, Quan H, Fields TA, McCall SJ, Yu MJ, Kourany WM, Frey CW, Le TH. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am J Physiol Renal Physiol. 2007;292:F533-F544
20. Zhang L, Peppel K, Sivashanmugam P, Orman ES, Brian L, Exum ST, Freedman NJ. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2007; 27:1087-1094
21. Brandes RP. Role of NADPH oxidases in the control of vascular gene expression. Antioxid Redox Signal. 2003;5:803-811
22. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299
23. Berk BC, Vallega G, Muslin AJ, Gordon HM, Canessa M, Alexander RW. Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na+/H+ exchange. J Clin Invest. 1989;83:822-829
24. Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension. 1989;13:589-597
25. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat: role of cellular hypertrophy, hyperploidy, and hyperplasia. CircRes. 1982;51:280-289
26. Resink TJ, Scott-Burden T, Jones CR, Baur U, Buhler FR. Atrial natriuretic peptide: binding and cyclic GMP response in cultured vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens. 1989;2:32-39
27. Singh A, Sventek P, Lariviere R, Thibault G, Schiffrin EL. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats. Am J Hypertens. 1996;9:867-877
28. Lemercier JN, Meier BW, Gomez JD, Thompson JA. Inhibition of glutathione S-transferase P1-1 in mouse lung epithelial cells by the tumor promoter 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT-quinone methide): protein adducts investigated by electrospray mass spectrometry. Chem Res Toxicol. 2004;17:1675-1683
29. Chanas SA, Jiang Q, McMahon M, McWalter GK, McLellan LI, Elcombe CR, Henderson CJ, Wolf CR, Moffat GJ, Itoh K, Yamamoto M, Hayes JD. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J. 2002;365:405-416
30. Kuhel DG, Zhu B, Witte DP, Hui DY. Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler Thromb Vasc Biol. 2002; 2:955-960
31. Ikeda S, Hawes NL, Chang B, Avery CS, Smith RS, Nishina PM. Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice. Invest Ophthalmol Vis Sci. 1999;40:1874-1878
32. Seidegard J, DePierre JW, Pero RW. Hereditary interindividual differences in the glutathione transferase activity towards trans-stilbeen oxide in resting human mononuclear leukocytes are due to a particular isozymes(s). Carcinogenesis. 1985;6:1211-1216
33. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 1999;401:79-82
34. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478
35. Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, Ichijo H, Choi EJ. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem. 2001;276:12749-12755
36. Dorion S, Lambert H, Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem. 2002;277:30792-30797
37. Squadrito F, Minutoli L, Esposito M, Bitto A, Marini H, Seminara P, Crisafulli A, Passaniti M, Adamo EB, Marini R, Guarini S, Altavilla D. Lipid peroxidation triggers both c-Jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK) activation and neointimal hyper-plasia induced by cessation of blood flow in the mouse carotid artery. Atherosclerosis. 2005;178:295-302
38. Liu CS, Tsai CS. Enhanced lipid peroxidation in epileptics with null genotype of glutathione S-transferase M1 and intractable seizure. Jpn J Pharmacol. 2002;90:291-294